Lapatinib Terminated Phase 1 / 2 Trials for HER2 Positive Metastatic Breast Cancers Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs